Total Payments
$3,284
2024 Payments
$343.04
Companies
20
Transactions
79
Medicare Patients
792
Medicare Billing
$67,801
Payment Breakdown by Category
Food & Beverage$1,999 (60.9%)
Travel$1,285 (39.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,999 | 73 | 60.9% |
| Travel and Lodging | $1,285 | 6 | 39.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $1,359 | 7 | $0 (2023) |
| ABBVIE INC. | $263.08 | 23 | $0 (2024) |
| UCB, Inc. | $254.07 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $214.61 | 6 | $0 (2019) |
| Stryker Corporation | $209.77 | 2 | $0 (2018) |
| Biogen, Inc. | $179.12 | 3 | $0 (2021) |
| Lilly USA, LLC | $168.69 | 9 | $0 (2024) |
| Amgen Inc. | $121.19 | 1 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $109.01 | 2 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $93.31 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $343.04 | 27 | ABBVIE INC. ($206.12) |
| 2023 | $358.56 | 15 | Lilly USA, LLC ($133.47) |
| 2022 | $1,405 | 12 | Intuitive Surgical, Inc. ($1,285) |
| 2021 | $30.53 | 2 | UCB, Inc. ($18.53) |
| 2019 | $295.03 | 9 | Novartis Pharmaceuticals Corporation ($167.16) |
| 2018 | $388.49 | 6 | Amgen Inc. ($121.19) |
| 2017 | $463.31 | 8 | Biogen, Inc. ($96.83) |
All Payment Transactions
79 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/04/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Neurology | ||||||
| 10/01/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.32 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.89 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.05 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/07/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Neurology | ||||||
| 07/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.31 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.21 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.87 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.67 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.74 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $33.77 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.91 | General |
| Category: NEUROSCIENCE | ||||||
| 05/28/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.15 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2024 | ABBVIE INC. | BOTOX (Biological), UBRELVY | Food and Beverage | In-kind items and services | $9.23 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/08/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Neuroscience | ||||||
| 05/02/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.23 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Neurology | ||||||
| 04/02/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.67 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/06/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Neurology | ||||||
| 02/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $3.55 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 176 | 214 | $33,747 | $16,562 |
| 2022 | 5 | 171 | 210 | $32,183 | $15,941 |
| 2021 | 8 | 221 | 251 | $33,180 | $16,989 |
| 2020 | 6 | 224 | 245 | $36,634 | $18,308 |
Total Patients
792
Total Services
920
Medicare Billing
$67,801
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 63 | 93 | $13,020 | $6,176 | 47.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 31 | 31 | $6,440 | $2,988 | 46.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 39 | $5,964 | $2,506 | 42.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $3,363 | $1,944 | 57.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 15 | 16 | $2,832 | $1,547 | 54.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 16 | $2,128 | $1,403 | 65.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 52 | 76 | $10,648 | $5,401 | 50.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 48 | $7,224 | $3,337 | 46.2% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 26 | 26 | $3,424 | $1,977 | 57.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 17 | 17 | $3,520 | $1,810 | 51.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 13 | 13 | $2,353 | $1,369 | 58.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $2,354 | $1,046 | 44.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 19 | 19 | $2,660 | $1,001 | 37.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 44 | 51 | $7,150 | $3,671 | 51.3% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 40 | 40 | $5,240 | $3,117 | 59.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 21 | 27 | $4,158 | $1,888 | 45.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 17 | 17 | $3,518 | $1,739 | 49.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 21 | 21 | $2,946 | $1,336 | 45.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 12 | 12 | $2,202 | $1,292 | 58.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 27 | $2,664 | $1,265 | 47.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 25 | 27 | $2,542 | $1,231 | 48.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 13 | 16 | $1,538 | $909.88 | 59.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 11 | 13 | $1,222 | $540.70 | 44.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 79 | 83 | $14,691 | $8,900 | 60.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 55 | 70 | $9,800 | $4,005 | 40.9% |
About Dr. Ali Saeed, MD
Dr. Ali Saeed, MD is a Neurology healthcare provider based in Owosso, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2011. The National Provider Identifier (NPI) number assigned to this provider is 1003103201.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ali Saeed, MD has received a total of $3,284 in payments from pharmaceutical and medical device companies, with $343.04 received in 2024. These payments were reported across 79 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,999).
As a Medicare-enrolled provider, Saeed has provided services to 792 Medicare beneficiaries, totaling 920 services with total Medicare billing of $67,801. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Owosso, MI
- Active Since 07/08/2011
- Last Updated 02/14/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1003103201
Products in Payments
- Da Vinci Surgical System (Device) $1,359
- GILENYA (Drug) $172.75
- EMGALITY (Drug) $168.69
- Briviact (Drug) $145.28
- TREVO (Device) $118.80
- BOTOX (Biological) $112.67
- APTIOM (Drug) $109.01
- XARELTO (Drug) $93.31
- Trevo (Device) $90.97
- UBRELVY (Drug) $66.25
- Nayzilam (Drug) $60.91
- COPAXONE (Drug) $52.22
- DUOPA (Drug) $44.83
- AIMOVIG (Biological) $41.86
- QULIPTA (Drug) $39.33
- ADLARITY (Drug) $27.54
- OCREVUS (Biological) $27.37
- Fintepla (Drug) $26.01
- AJOVY (Drug) $25.65
- NUPLAZID (Drug) $24.87
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Owosso
Dr. Rany Aburashed, D.o, D.O
Neurology — Payments: $1.2M
Neurology $1.2M
Robert Pace, Md, MD
Neurology — Payments: $901,128
Neurology $901,128
Margaret Frey, Do, DO
Neurology — Payments: $409,351
Neurology $409,351
Rosemarie Walch, Do, DO
Neurology — Payments: $400,076
Neurology $400,076
Cara Leahy, Do, DO
Neurology — Payments: $115,077
Neurology $115,077
Anthony Brune, Do, DO
Neurology — Payments: $18,437
Neurology $18,437